1. Home
  2. SPTX vs HBNC Comparison

SPTX vs HBNC Comparison

Compare SPTX & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$18.60

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Horizon Bancorp Inc.

HBNC

Horizon Bancorp Inc.

N/A

Current Price

$19.04

Market Cap

962.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SPTX
HBNC
Founded
2024
1873
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
962.4M
IPO Year
2026
1995

Fundamental Metrics

Financial Performance
Metric
SPTX
HBNC
Price
$18.60
$19.04
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
★ $38.29
$22.90
AVG Volume (30 Days)
155.6K
★ 405.8K
Earning Date
11-05-2026
10-21-2026
Dividend Yield
N/A
★ 3.40%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.00
Revenue
N/A
N/A
Revenue This Year
N/A
$8.30
Revenue Next Year
N/A
$5.34
P/E Ratio
★ N/A
$18.87
Revenue Growth
N/A
N/A
52 Week Low
$17.59
$14.97
52 Week High
$28.38
$21.04

Technical Indicators

Market Signals
Indicator
SPTX
HBNC
Relative Strength Index (RSI) 44.86 31.44
Support Level $18.72 $18.70
Resistance Level $22.75 $18.88
Average True Range (ATR) 1.81 0.32
MACD -0.26 -0.06
Stochastic Oscillator 32.71 2.76

Price Performance

Historical Comparison
SPTX
HBNC

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

Share on Social Networks: